D P Mertz|T Wick - JoVE Visualize

Showing results (41-50 of 59) with videos related to

Pageof 6

Sort By:

Medizinische Klinik|December 21, 1979

[The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)]D P Mertz, H Loewer, I Suermann

MMW, Munchener Medizinische Wochenschrift|August 25, 1978

[Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)]D P Mertz, I Suermann, E Göhmann

Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1982

Bezafibrate: lack of effect on creatinine excretion and muscular proteinsD P Mertz, P D Lang, J Vollmar

Klinische Wochenschrift|November 1, 1977

[Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)]D Janzen, D P Mertz, E Scheiffele, et al.

Psychological Reports|July 13, 2016

Transgenerational Authenticity Measurement: A Comment on Ito et al. (2009)James Giannini, Daniel T Wick

Medizinische Klinik|January 14, 1977

[Chances in the serum lipid values after conversion to a "reasonable" diet (author's transl)]D P Mertz, H D Wobbe, A Berger, et al.

Medizinische Klinik|January 14, 1977

[Errors in practising a so-called "reasonable" regimen (author's transl)]H D Wobbe, D P Mertz, A Berger, et al.

Oncogene|November 16, 1995

Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16S T Wick, M M Dubay, I Imanil, et al.

ACS Nano|November 19, 2015

Direct Analysis of Gene Synthesis Reactions Using Solid-State NanoporesSpencer Carson, Scott T Wick, Peter A Carr, et al.

Nanoscale|June 5, 2015

In situ microfluidic SERS assay for monitoring enzymatic breakdown of organophosphatesVladimir Liberman, Kimberly Hamad-Schifferli, Todd A Thorsen, et al.

Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:

Pageof 6

Medizinische Klinik|December 21, 1979

[The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)]D P Mertz, H Loewer, I Suermann

MMW, Munchener Medizinische Wochenschrift|August 25, 1978

[Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)]D P Mertz, I Suermann, E Göhmann

Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1982

Bezafibrate: lack of effect on creatinine excretion and muscular proteinsD P Mertz, P D Lang, J Vollmar

Klinische Wochenschrift|November 1, 1977

[Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)]D Janzen, D P Mertz, E Scheiffele, et al.

Psychological Reports|July 13, 2016

Transgenerational Authenticity Measurement: A Comment on Ito et al. (2009)James Giannini, Daniel T Wick

Medizinische Klinik|January 14, 1977

[Chances in the serum lipid values after conversion to a "reasonable" diet (author's transl)]D P Mertz, H D Wobbe, A Berger, et al.

Medizinische Klinik|January 14, 1977

[Errors in practising a so-called "reasonable" regimen (author's transl)]H D Wobbe, D P Mertz, A Berger, et al.

Oncogene|November 16, 1995

Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16S T Wick, M M Dubay, I Imanil, et al.

ACS Nano|November 19, 2015

Direct Analysis of Gene Synthesis Reactions Using Solid-State NanoporesSpencer Carson, Scott T Wick, Peter A Carr, et al.

Nanoscale|June 5, 2015

In situ microfluidic SERS assay for monitoring enzymatic breakdown of organophosphatesVladimir Liberman, Kimberly Hamad-Schifferli, Todd A Thorsen, et al.

Pageof 6